Pfizer
With annual revenues (2003) of $45.2 billion, Pfizer is wealthier and more powerful than quite a few countries -- and it's not afraid to assert itself. Pfizer has been one of the prime movers in the U.S. battles of Medicare and drug reimportation.
Consumer reaction to Pfizer's political activities is often spirited and is covered more completely in our news section. We also hear from consumers who have bad reactions to Pfizer drugs. Click the links to learn more.
Complaints about Pfizer Drugs
News
- Pfizer Suspends Sale of Arsenic-Containing Animal Drug
- Pfizer To Recall One Lot Of Lipitor
- Pfizer Recalling Some Bottles of Lipitor
- Pfizer Pays Record $2.3 Billion Settlement Over Illegal Marketing Charges
- Pfizer Pays $894 Million to Settle NSAID Claims
- Anti-Smoking Drug Chantix Linked to Seizures, Heart Problems, Diabetes
- Pfizer Hit With Second Data Breach In Two Months
- Pfizer Keeps Data Breach Quiet
- Suit Charges Pfizer Misled Seniors About Lipitor
- FDA Refuses to Approve Pfizer Cox-2 Drug
- Minnesota Pension Fund Blasts Pfizer
- Pfizer Cuts Off Selected Canadian Pharmacies
- Pfizer Cuts Off Two Canadian Drug Wholesalers
- Can Pfizer Prevent Celebrex Ban?
- Pfizer Will Offer Deep Discounts to Uninsured
- Devilish Viagra Ads Pulled